Help

BI’s Article search uses Boolean search capabilities. If you are not familiar with these principles, here are some quick tips.

To search specifically for more than one word, put the search term in quotation marks. For example, “workers compensation”. This will limit your search to that combination of words.

To search for a combination of terms, use quotations and the & symbol. For example, “hurricane” & “loss”.

Employee Benefits

Cigna to offer biosimilar Humira with zero out-of-pocket costs

April 26, 2024 Reprints

Cigna Group is set to offer biosimilar versions of AbbVie's arthritis drug Humira with no out-of-pocket costs to eligible U.S. patients starting June1, Yahoo! Finance reports. The insurer will stock high- and low-concentration biosimilars from Boehringer Ingelheim, Teva, and Alvotech at its Accredo pharmacy. The move, which could save around $3,500 per year for some of the 100,000 Accredo patients currently using Humira or its biosimilars, is expected to challenge AbbVie's 98% market share for Humira.

Help

Cigna to offer biosimilar Humira with zero out-of-pocket costs

Readers Poll

Most Read in Employee Benefits

Sign up now for free access to this article and much more.

If you are already registered with Business Insurance, click here to Login

Please tell us a bit more about yourself in order to continue

About

Advertise

Reprints and Licensing

Resources